You have read all your free articles, to continue reading subscribe to read the rest of this content.
Zelluna Immunotherapy has announced an investment from Takeda Ventures, the strategic investing arm of Takeda. TVI investment joins Zelluna’s latest financing round, the company states. “We are delighted to have TVI as a strategic investor in Zelluna. The company has developed very well frAlready a subscriber Login You have read…
The Thuesday morning of NLSDays started off with a super session on Financing and both the expert panel and the presenting companies shared valuable insights. Starting and evolving a company requires funds and in this session, five Nordic life science companies at very different stages shared theAlready a subscriber Login…
Bactiguard and Zimmer Biomet have agreed to expand the global license partnership, that was initiated in 2019, to cover multiple product segments. The extended exclusive license agreement covers implants for joint reconstruction (hips and knees), sports medicine, craniomaxillofacial and thoracic Already a subscriber Login You have read all your free…
The agreement will allow it to expand the company's US offering with products that are complementary to Cerament, it states. The company will start selling and marketing selected Collagen Matrix bone graft substitute products under its own brand name, and through its own US distribution network iAlready a subscriber Login…
